Literature DB >> 9624311

Clinical course of gamma-hydroxybutyrate overdose.

R L Chin1, K A Sporer, B Cullison, J E Dyer, T D Wu.   

Abstract

STUDY
OBJECTIVE: To describe the clinical characteristics and course of gamma-hydroxybutyrate (GHB) overdose.
METHODS: We assembled a retrospective series of all cases of GHB ingestion see in an urban public-hospital emergency department and entered in a computerized database January 1993 through December 1996. From these cases we extracted demographic information, concurrent drug use, vital signs, Glasgow Coma Scale (GCS) score, laboratory values, and clinical course.
RESULTS: Sixty-one (69%) of the 88 patients were male. The mean age was 28 years. Thirty-four cases (39%) involved coingestion of ethanol, and 25 (28%) involved coingestion of another drug, most commonly amphetamines. Twenty-five cases (28%) had a GCS score of 3, and 28 (33%) had scores ranging from 4 through 8. The mean time to regained consciousness from initial presentation among nonintubated patients with an initial GCS of 13 or less was 146 minutes (range, 16-389). Twenty-two patients (31%) had an initial temperature of 35 degrees C or less. Thirty-two (36%) had asymptomatic bradycardia; in 29 of these cases, the initial GCS score was 8 or less. Ten patients (11%) presented with hypotension (systolic blood pressure < or = 90 mm Hg); 6 of these patients also demonstrated concurrent bradycardia. Arterial blood gases were measured in 30 patients; 21 had a PCO2 of 45 or greater, with pH ranging from 7.24 to 7.34, consistent with mild acute respiratory acidosis. Twenty-six patients (30%) had an episode of emesis; in 22 of these cases, the initial GCS was 8 or less.
CONCLUSION: In our study population, patients who overdosed on GHB presented with a markedly decreased level of consciousness. Coingestion of ethanol or other drugs is common, as are bradycardia, hypothermia, respiratory acidosis, and emesis. Hypotension occurs occasionally. Patients typically regain consciousness spontaneously within 5 hours of the ingestion.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9624311

Source DB:  PubMed          Journal:  Ann Emerg Med        ISSN: 0196-0644            Impact factor:   5.721


  21 in total

1.  Traumatic brain injury after a motor vehicle accident: fact or "fantasy"?

Authors:  D G Caldicott; N Edwards
Journal:  Emerg Med J       Date:  2001-11       Impact factor: 2.740

Review 2.  Street drug abuse leading to critical illness.

Authors:  Babak Mokhlesi; Prasad S Garimella; Aaron Joffe; Valerie Velho
Journal:  Intensive Care Med       Date:  2004-03-04       Impact factor: 17.440

3.  Gamma-hydroxybutyrate and ethanol effects and interactions in humans.

Authors:  Dung Thai; Jo Ellen Dyer; Neal L Benowitz; Christine A Haller
Journal:  J Clin Psychopharmacol       Date:  2006-10       Impact factor: 3.153

Review 4.  Safety overview of postmarketing and clinical experience of sodium oxybate (Xyrem): abuse, misuse, dependence, and diversion.

Authors:  Y Grace Wang; Todd J Swick; Lawrence P Carter; Michael J Thorpy; Neal L Benowitz
Journal:  J Clin Sleep Med       Date:  2009-08-15       Impact factor: 4.062

5.  gamma-aminobutyric acid type B receptors are expressed and functional in mammalian cardiomyocytes.

Authors:  P Lorente; A Lacampagne; Y Pouzeratte; S Richards; B Malitschek; R Kuhn; B Bettler; G Vassort
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-18       Impact factor: 11.205

6.  Monocarboxylate Transporter Inhibition with Osmotic Diuresis Increases γ-Hydroxybutyrate Renal Elimination in Humans: A Proof-of-Concept Study.

Authors:  Marilyn E Morris; Bridget L Morse; Gloria J Baciewicz; Matthew M Tessena; Nicole M Acquisto; David J Hutchinson; Robert Dicenzo
Journal:  J Clin Toxicol       Date:  2011-11-10

7.  Pharmacokinetics and pharmacodynamics of γ-hydroxybutyrate in healthy subjects.

Authors:  Matthias E Liechti; Boris B Quednow; Evangelia Liakoni; Dario Dornbierer; Robin von Rotz; Maria Salomé Gachet; Jürg Gertsch; Erich Seifritz; Oliver G Bosch
Journal:  Br J Clin Pharmacol       Date:  2016-02-25       Impact factor: 4.335

Review 8.  Illicit gamma-hydroxybutyrate (GHB) and pharmaceutical sodium oxybate (Xyrem): differences in characteristics and misuse.

Authors:  Lawrence P Carter; Daniel Pardi; Jane Gorsline; Roland R Griffiths
Journal:  Drug Alcohol Depend       Date:  2009-06-02       Impact factor: 4.492

9.  An investigation of flumazenil to antagonize gamma-hydroxybutyrate intoxication in a murine model.

Authors:  David C Lee; Wayne A Satz; Timothy Dougherty; Tucker Greene
Journal:  J Med Toxicol       Date:  2006-06

10.  Systematic assessment of gamma hydroxybutyrate (GHB) effects during and after acute intoxication.

Authors:  Susan Y Kim; Judith C Barker; Ilene B Anderson; Jo Ellen Dyer; Gillian Earnest; Paul D Blanc
Journal:  Am J Addict       Date:  2008 Jul-Aug
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.